Michael N. Needle
Impact in
Papers in
-
- Renal cell carcinoma treatment 15
- Genetics 19
- Glioma Diagnosis and Treatment 19
- Co-authors
- Robert J. Mayer (2 shared papers)Neal J. Meropol (1 shared paper)Leonard B. Saltz (1 shared paper)Patrick J. Loehrer (1 shared paper)Justin Kopit (1 shared paper)Peter C. Phillips∥ (13 shared papers)Patricia Molloy (13 shared papers)Gregory H. Reaman (6 shared papers)
- Journals
- Journal of Clinical Oncology (24 papers)Cancer (5 papers)Annals of Oncology (4 papers)Journal of neurosurgery (4 papers)Blood (3 papers)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Michael N. Needle
73 papers receiving 5.1k citations
Michael N. Needle's Hit Papers
Peers
Comparison fields: 5 of 101
- Genetics 893
- Oncology 2.0k
- Neurology 854
- Pulmonary and Respiratory Medicine 1.4k
- Ophthalmology 347
Countries citing papers authored by Michael N. Needle
This map shows the geographic impact of Michael N. Needle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael N. Needle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael N. Needle more than expected).
Fields of papers citing papers by Michael N. Needle
This network shows the impact of papers produced by Michael N. Needle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael N. Needle. The network helps show where Michael N. Needle may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael N. Needle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor Hit paper breakdown → | 2004 | 1383 |
| 2 | 1997 | 427 | |
| 3 | 2004 | 391 | |
| 4 | 2002 | 379 | |
| 5 | 2006 | 234 | |
| 6 | 2000 | 194 | |
| 7 | 1997 | 175 | |
| 8 | 2019 | 168 | |
| 9 | 2005 | 163 | |
| 10 | 1997 | 146 | |
| 11 | 2005 | 130 | |
| 12 | 2003 | 110 | |
| 13 | 1997 | 97 | |
| 14 | 1997 | 81 | |
| 15 | 1995 | 80 | |
| 16 | 2004 | 80 | |
| 17 | 2012 | 73 | |
| 18 | 1994 | 64 | |
| 19 | 1996 | 61 | |
| 20 | 2002 | 55 |
About Michael N. Needle
Michael N. Needle is a scholar working on Pulmonary and Respiratory Medicine, Genetics, Oncology, Neurology and Cancer Research, having authored 73 papers that have together received 5.3k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (19 papers), Renal cell carcinoma treatment (15 papers), Cancer Genomics and Diagnostics (12 papers), Neurofibromatosis and Schwannoma Cases (10 papers), Colorectal Cancer Treatments and Studies (8 papers), Neuroblastoma Research and Treatments (6 papers), Cancer Treatment and Pharmacology (6 papers) and Economic and Financial Impacts of Cancer (6 papers). The work is most often cited by research in Genetics (893 citations), Oncology (2.0k citations), Neurology (854 citations), Pulmonary and Respiratory Medicine (1.4k citations) and Ophthalmology (347 citations). Michael N. Needle has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Robert J. Mayer, Neal J. Meropol, Leonard B. Saltz, Patrick J. Loehrer, Justin Kopit, Peter C. Phillips∥, Patricia Molloy, Gregory H. Reaman, Arthur Rosenberg and Joann L. Ater. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Annals of Oncology, Journal of neurosurgery and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.